Crestor Filmuhúðuð tafla 40 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

crestor filmuhúðuð tafla 40 mg

astrazeneca a/s - rosuvastatinum kalsíum - filmuhúðuð tafla - 40 mg

Rosuvastatin Xiromed Filmuhúðuð tafla 10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

rosuvastatin xiromed filmuhúðuð tafla 10 mg

medical valley invest ab - rosuvastatinum kalsíum - filmuhúðuð tafla - 10 mg

Flutiform (Affilia) Innúðalyf, dreifa 250 míkróg/10 míkróg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

flutiform (affilia) innúðalyf, dreifa 250 míkróg/10 míkróg

mundipharma a/s - fluticasonum própíónat; formoterolum fúmarat - innúðalyf, dreifa - 250 míkróg/10 míkróg

Varilrix Stungulyfsstofn og leysir, lausn 2.000 PFU bóluefni Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

varilrix stungulyfsstofn og leysir, lausn 2.000 pfu bóluefni

glaxosmithkline pharma a/s - varicella-zoster virus - stungulyfsstofn og leysir, lausn - 2.000 pfu bóluefni

Venlafaxin Medical Valley Forðatafla 225 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

venlafaxin medical valley forðatafla 225 mg

medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 225 mg

Pregabalin Krka Hart hylki 225 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

pregabalin krka hart hylki 225 mg

krka, d.d., novo mesto - pregabalinum inn - hart hylki - 225 mg

Harpatinum Mjúkt hylki 225 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

harpatinum mjúkt hylki 225 mg

florealis ehf. - devil´s claw dry extract ethanolic 60% (v/v) (4.4-5.0:1) - mjúkt hylki - 225 mg

Monoprost Augndropar, lausn í stakskammtaíláti 50 míkróg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

monoprost augndropar, lausn í stakskammtaíláti 50 míkróg/ml

laboratoires thea* - latanoprostum inn - augndropar, lausn í stakskammtaíláti - 50 míkróg/ml

Tenutex Húðfleyti 20 mg/g + 225 mg/g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

tenutex húðfleyti 20 mg/g + 225 mg/g

bioglan ab - disulfiramum inn; benzylis benzoas - húðfleyti - 20 mg/g + 225 mg/g

Cevenfacta Evrópusambandið - íslenska - EMA (European Medicines Agency)

cevenfacta

laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorrhagics - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.